How AstraZeneca is quietly rewiring Boston’s AI ecosystem
In recent years, AstraZeneca has done more in Boston than expand office space. It’s been building an AI-first innovation engine that blends biotech, machine learning, clinical data, and academic collaboration into something that feels less like traditional pharma R&D and more like a living system. Think less corporate campus, more distributed intelligence network with pipettes….
